Loading data for NRXS — first visit, this takes a few seconds.
NeurAxis, Inc. (NRXS) Stock Price, Analysis & Data
Intrinsic Value
Analyst Forecast
Stock Forecasts →Latest Earnings
| Reported | Vs estimate | YoY Change | |
|---|---|---|---|
| Revenue | $1.93M | n/a | +115.72% |
| EPS | -$0,19 | +$0,13 | +42.42% |
Metrics
- Bid
- 0
- Market Cap
- 73.2M
- Revenue (ttm)
- 5.32M
- Net Income (ttm)
- -8.45M
- 1.45
- -0.76
- n/a
- -21.59
- P/B (ttm)
- 10.80
- P/S (ttm)
- 13.77
- Earnings Date
- n/a
- Ask
- 0
- Volume
- 50,244
- Avg. Volume (20D)
- 81,156
- Open
- 5.70
- Previous Close
- 5.73
- Day's Range
- 5.57 - 5.72
- 52-Week Range
- 2.21 - 9.33
- Analyst
- n/a
- Price Target
- n/a
- Dividends
- n/a
- Ex-Dividend Date
- n/a
About NeurAxis, Inc.
View profile →NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Industry Biotechnology
Sector Healthcare
IPO Date Aug 9, 2023
Employees 24
Stock Exchange NYSE American
Ticker Symbol NRXS
Website https://neuraxis.com